Sorafenib safety evaluation: Real-world analysis of adverse events from the FAERS database

Background: Sorafenib is approved for the targeted therapy of cancers such as liver cancer and renal cancer. Given its widespread use, drug-related adverse events have received attention, and the post-marketing regulatory link is crucial. Objective: By using the FAERS database to mine the adverse ev...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Lin Ning, Yuan Tian, Di Chen, Jie Han, Guanyue Xie, Jianguang Sun
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2024-09-01
Edice:	Heliyon
Témata:	Sorafenib Cancer FAERS Adverse events Pharmacovigilance
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2405844024133798
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!